PARP inhibitor
December 12, 2012
Clinical Trials for Hereditary Cancer: Where the Rubber Meets the Road
Posted in:
Research
Tags:
BRCA ,
Breast Cancer ,
Hereditary Cancer Research ,
BRCA1 ,
BRCA2 ,
FDA ,
Clinical Trials ,
PARP Inhibitor
October 12, 2017
Patients Weigh In On Review of PARP Inhibitors for Treatment of Ovarian Cancer
Posted in:
Laws, Protections And Public Policy ,
Cancer Treatment
Tags:
Ovarian Cancer ,
PARP Inhibitor ,
Patient Advocacy
April 12, 2018
PARP Inhibitors and Hereditary Cancer: What’s New?
Posted in:
Research ,
Cancer Treatment
Tags:
BRCA ,
Ovarian Cancer ,
Genetic Testing ,
BRCA1 ,
BRCA2 ,
PALB2 ,
Pancreatic Cancer ,
ATM ,
Gene Panel Testing ,
Metastatic Breast Cancer ,
Ovarian Cancer Treatment ,
PARP Inhibitor ,
Cancer Research ,
Advanced Breast Cancer ,
Inherited Mutations ,
Prostate Cancer Treatment ,
Metastatic Prostate Cancer ,
Cancer Targeted Therapy
Subscribe to our Blog
Enter your email address to subscribe to this blog and receive a monthly digest of new posts.
November 19, 2019
FORCE Launches the New XRAY-Ovarian Cancer Program
Posted in:
XRAY
Tags:
Hereditary Cancer ,
Ovarian Cancer ,
PARP Inhibitor ,
Cancer Research
January 06, 2020
New PARP Inhibitor Approval for Pancreatic Cancer
Posted in:
XRAY ,
Cancer Treatment
Tags:
Pancreatic Cancer ,
PARP Inhibitor ,
Pancreatic Cancer Treatment ,
Hereditary Pancreatic Cancer
August 24, 2020
PARP Inhibitor Treatment Is Helping My Pancreatic Cancer
Posted in:
Stories
Tags:
BRCA1 ,
Pancreatic Cancer ,
PARP Inhibitor ,
Pancreatic Cancer Treatment ,
Men With Mutations